| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |